| Literature DB >> 27640113 |
Francesco Cappello1, Mariantonia Logozzi2, Claudia Campanella1, Celeste Caruso Bavisotto1, Antonio Marcilla3, Francesca Properzi2, Stefano Fais2.
Abstract
Despite considerable research efforts, the finding of reliable tumor biomarkers remains challenging and unresolved. In recent years a novel diagnostic biomedical tool with high potential has been identified in extracellular nanovesicles or exosomes. They are released by the majority of the cells and contain detailed molecular information on the cell of origin including tumor hallmarks. Exosomes can be isolated from easy accessible body fluids, and most importantly, they can provide several biomarkers, with different levels of specificity. Recent clinical evidence shows that the levels of exosomes released into body fluids may themselves represent a predictive/diagnostic of tumors, discriminating cancer patients from healthy subjects. The aim of this review is to highlight these latest challenging findings to provide novel and groundbreaking ideas for successful tumor early diagnosis and follow-up.Entities:
Keywords: Biomarkers; Body fluids; Early diagnosis; Exosomes; Extracellular vesicles; Follow-up; Prostate cancer
Mesh:
Substances:
Year: 2016 PMID: 27640113 DOI: 10.1016/j.ejps.2016.09.010
Source DB: PubMed Journal: Eur J Pharm Sci ISSN: 0928-0987 Impact factor: 4.384